Received May 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | IM / LA |
skin inflammation; burning sensation; red; Bumpy; This non-serious case was reported by a consumer via call center representative and described the occurrence of skin inflammation in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included skin cancer. On an unknown date, the patient received the 1st dose of Shingrix (intramuscular, left arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced skin inflammation (Verbatim: skin inflammation), burning sensation (Verbatim: burning sensation), erythema (Verbatim: red) and swelling (Verbatim: Bumpy). The outcome of the skin inflammation, burning sensation, erythema and swelling were not resolved. It was unknown if the reporter considered the skin inflammation, burning sensation, erythema and swelling to be related to Shingrix. It was unknown if the company considered the skin inflammation, burning sensation, erythema and swelling to be related to Shingrix. Additional Information: GSK Receipt Date: 25-APR-2025 The patient reports on April 25th, 2025, that she got her 1st dose of Shingrix Vaccine about 3 weeks ago. The patient reported that broke out with a skin inflammation on the arms and legs, but it was not like a rash. She reports it was like a burning sensation, and states, it was like a bad sunburn, like blotchy it was red and bumpy. The patient reports it's been 3 weeks and has not resolved. The patient reports some medical history information. No additional event was reported.
Skin cancer